Core Insights - Shandong Huiyan Tong Medical Technology Group Co., Ltd. (referred to as Huiyan Tong) has reported on the progress of its initial public offering (IPO) guidance work, with Zhongtai Securities acting as the advisory institution [2] - The IPO guidance was officially filed on July 28, 2020, and the current concentrated guidance period is from July 1, 2025, to September 30, 2025, lasting for three months [2] - The guidance team has identified a betting agreement between the actual controller and Suzhou Dingfeng Jiuding Investment Center (Limited Partnership) and Suzhou Yinli Jiuding Investment Center (Limited Partnership), and is actively facilitating communication regarding this issue [2] Company Overview - Huiyan Tong was established on May 31, 2004, with a registered capital of 81.5 million yuan, and its business scope includes economic trade consulting, sales of Class II and III medical devices, and computer system services [3] - The company is primarily owned by its chairman and general manager, Gao Fujun, who holds 56.06% of the shares, with Jiuding Investment as a minority shareholder [3] - Gao Fujun is a prominent figure in the medical field, serving as the director of the Lunan Eye Hospital and holding various leadership roles in medical associations, recognized for his contributions to charity and healthcare [3]
慧眼通IPO辅导：董事长高富军持股56%，系鲁南眼科医院创始人
Sou Hu Cai Jing·2025-10-14 10:31